Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 59

1.

Use of FreeStyle Libre Flash Monitor Register in the Netherlands (FLARE-NL1): Patient Experiences, Satisfaction, and Cost Analysis.

Fokkert MJ, Damman A, van Dijk PR, Edens MA, Abbes S, Braakman J, Slingerland RJ, Dikkeschei LD, Dille J, Bilo HJG.

Int J Endocrinol. 2019 Nov 3;2019:4649303. doi: 10.1155/2019/4649303. eCollection 2019.

2.

Accuracy of pre-hospital HEART score risk classification using point of care versus high sensitive troponin in suspected NSTE-ACS.

van Dongen DN, Fokkert MJ, Tolsma RT, van der Sluis A, Slingerland RJ, Badings EA, van 't Hof AWJ, Ottervanger JP.

Am J Emerg Med. 2019 Oct 8. pii: S0735-6757(19)30597-2. doi: 10.1016/j.ajem.2019.158448. [Epub ahead of print]

PMID:
31699426
3.

In-Hospital Healthcare Utilization, Outcomes, and Costs in Pre-Hospital-Adjudicated Low-Risk Chest-Pain Patients.

van Dongen DN, Ottervanger JP, Tolsma R, Fokkert M, van der Sluis A, van 't Hof AWJ, Badings E, Slingerland RJ.

Appl Health Econ Health Policy. 2019 Dec;17(6):875-882. doi: 10.1007/s40258-019-00502-6.

PMID:
31388939
4.

An Unexpected Low HbA1c: Measurement Error or Interpretation Problem?

Lenters-Westra E, den Besten G, Slingerland RJ.

Clin Chem. 2019 Aug;65(8):1062-1063. doi: 10.1373/clinchem.2019.301952. No abstract available.

PMID:
31358503
5.

Impact of elevated HbA1c on long-term mortality in patients presenting with acute myocardial infarction in daily clinical practice: insights from a 'real world' prospective registry of the Zwolle Myocardial Infarction Study Group.

Hermanides RS, Kennedy MW, Kedhi E, van Dijk PR, Timmer JR, Ottervanger JP, Dambrink JH, Gosselink AM, Roolvink V, Miedema K, Slingerland RJ, Koopmans P, Bilo HJ, van 't Hof AW.

Eur Heart J Acute Cardiovasc Care. 2019 May 24:2048872619849921. doi: 10.1177/2048872619849921. [Epub ahead of print]

PMID:
31124695
7.

Pre-hospital risk assessment in suspected non-ST-elevation acute coronary syndrome: A prospective observational study.

van Dongen DN, Tolsma RT, Fokkert MJ, Badings EA, van der Sluis A, Slingerland RJ, van 't Hof AW, Ottervanger JP.

Eur Heart J Acute Cardiovasc Care. 2018 Nov 23:2048872618813846. doi: 10.1177/2048872618813846. [Epub ahead of print]

PMID:
30468395
8.

Repeat whole blood donors with a ferritin level of 30 μg/L or less show functional iron depletion.

Dijkstra A, van den Hurk K, Bilo HJG, Slingerland RJ, Vos MJ.

Transfusion. 2019 Jan;59(1):21-25. doi: 10.1111/trf.14935. Epub 2018 Oct 6.

PMID:
30291758
9.

Value of Prehospital Troponin Assessment in Suspected Non-ST-Elevation Acute Coronary Syndrome.

van Dongen DN, Fokkert MJ, Tolsma RT, Badings EA, van der Sluis A, Slingerland RJ, van 't Hof AWJ, Ottervanger JP.

Am J Cardiol. 2018 Nov 15;122(10):1610-1616. doi: 10.1016/j.amjcard.2018.07.037. Epub 2018 Aug 20.

PMID:
30262402
10.

Does Regulatory Really Intersect Reality in Glucose Measurement in the ICU? Is the Issue Testing Method Accuracy or Specimen Type?

DuBois JA, Slingerland RJ, Fokkert M, Roman A, Tran NK, Clarke W, Sartori DA, Palmieri TL, Malic A, Lyon ME, Lyon AW.

Crit Care Med. 2017 Nov;45(11):e1186-e1188. doi: 10.1097/CCM.0000000000002596. No abstract available.

PMID:
29028711
11.

Technical and clinical validation of the Greiner FC-Mix glycaemia tube.

van der Hagen EAE, Fokkert MJ, Kleefman AMD, Thelen MHM, van den Berg SAA, Slingerland RJ.

Clin Chem Lab Med. 2017 Aug 28;55(10):1530-1536. doi: 10.1515/cclm-2016-0944.

PMID:
28284032
12.

Performance of the FreeStyle Libre Flash glucose monitoring system in patients with type 1 and 2 diabetes mellitus.

Fokkert MJ, van Dijk PR, Edens MA, Abbes S, de Jong D, Slingerland RJ, Bilo HJ.

BMJ Open Diabetes Res Care. 2017 Feb 17;5(1):e000320. doi: 10.1136/bmjdrc-2016-000320. eCollection 2017.

13.

Bedside Glucose Monitoring-Is it Safe? A New, Regulatory-Compliant Risk Assessment Evaluation Protocol in Critically Ill Patient Care Settings.

DuBois JA, Slingerland RJ, Fokkert M, Roman A, Tran NK, Clarke W, Sartori DA, Palmieri TL, Malic A, Lyon ME, Lyon AW.

Crit Care Med. 2017 Apr;45(4):567-574. doi: 10.1097/CCM.0000000000002252.

14.

Whole Blood Donation Affects the Interpretation of Hemoglobin A1c.

Dijkstra A, Lenters-Westra E, de Kort W, Bokhorst AG, Bilo HJ, Slingerland RJ, Vos MJ.

PLoS One. 2017 Jan 24;12(1):e0170802. doi: 10.1371/journal.pone.0170802. eCollection 2017.

15.

Fast assessment and management of chest pain patients without ST-elevation in the pre-hospital gateway (FamouS Triage): ruling out a myocardial infarction at home with the modified HEART score.

Ishak M, Ali D, Fokkert MJ, Slingerland RJ, Tolsma RT, Badings E, van der Sluis A, van Eenennaam F, Mosterd A, Ten Berg JM, van 't Hof AW.

Eur Heart J Acute Cardiovasc Care. 2018 Mar;7(2):102-110. doi: 10.1177/2048872616687116. Epub 2017 Jan 13.

PMID:
28084079
16.

Can the Afinion HbA1c Point-of-Care instrument be an alternative method for the Tosoh G8 in the case of Hb-Tacoma?

Lenters-Westra E, Strunk A, Campbell P, Slingerland RJ.

Scand J Clin Lab Invest. 2017 Feb;77(1):2-7. Epub 2016 May 18.

PMID:
27191339
17.

Differences in interpretation of haemoglobin A1c values among diabetes care professionals.

Lenters-Westra E, Schindhelm RK, Bilo HJ, Groenier KH, Slingerland RJ.

Neth J Med. 2014 Nov;72(9):462-6.

18.

Biological variation of hemoglobin A1c: consequences for diagnosing diabetes mellitus.

Lenters-Westra E, Røraas T, Schindhelm RK, Slingerland RJ, Sandberg S.

Clin Chem. 2014 Dec;60(12):1570-2. doi: 10.1373/clinchem.2014.227983. Epub 2014 Sep 23. No abstract available.

19.

Fast assessment and management of chest pain without ST-elevation in the pre-hospital gateway: rationale and design.

Ishak M, Ali D, Fokkert MJ, Slingerland RJ, Dikkeschei B, Tolsma RT, Lichtveld RA, Bruins W, Boomars R, Bruheim K, van Eenennaam F, Timmers L, Voskuil M, Doevendans PA, Mosterd A, Hoes AW, ten Berg JM, van 't Hof AW; FAMOUS TRIAGE Study Group.

Eur Heart J Acute Cardiovasc Care. 2015 Apr;4(2):129-36. doi: 10.1177/2048872614549738. Epub 2014 Sep 8.

PMID:
25202026
20.

Three of 7 hemoglobin A1c point-of-care instruments do not meet generally accepted analytical performance criteria.

Lenters-Westra E, Slingerland RJ.

Clin Chem. 2014 Aug;60(8):1062-72. doi: 10.1373/clinchem.2014.224311. Epub 2014 May 27.

21.

Optimising drug prescribing and dispensing in subjects at risk for drug errors due to renal impairment: improving drug safety in primary healthcare by low eGFR alerts.

Joosten H, Drion I, Boogerd KJ, van der Pijl EV, Slingerland RJ, Slaets JP, Jansen TJ, Schwantje O, Gans RO, Bilo HJ.

BMJ Open. 2013 Jan 24;3(1). pii: e002068. doi: 10.1136/bmjopen-2012-002068.

22.

Haemoglobin A1c: Historical overview and current concepts.

Lenters-Westra E, Schindhelm RK, Bilo HJ, Slingerland RJ.

Diabetes Res Clin Pract. 2013 Feb;99(2):75-84. doi: 10.1016/j.diabres.2012.10.007. Epub 2012 Nov 20. Review.

PMID:
23176805
23.

Prognostic value of admission glycosylated hemoglobin and glucose in nondiabetic patients with ST-segment-elevation myocardial infarction treated with percutaneous coronary intervention.

Timmer JR, Hoekstra M, Nijsten MW, van der Horst IC, Ottervanger JP, Slingerland RJ, Dambrink JH, Bilo HJ, Zijlstra F, van 't Hof AW.

Circulation. 2011 Aug 9;124(6):704-11. doi: 10.1161/CIRCULATIONAHA.110.985911. Epub 2011 Jul 18.

PMID:
21768543
24.

One in five laboratories using various hemoglobin A1c methods do not meet the criteria for optimal diabetes care management.

Lenters-Westra E, Weykamp C, Schindhelm RK, Siebelder C, Bilo HJ, Slingerland RJ.

Diabetes Technol Ther. 2011 Apr;13(4):429-33. doi: 10.1089/dia.2010.0148. Epub 2011 Feb 28.

PMID:
21355726
25.

Self-monitoring of blood glucose: the use of the first or the second drop of blood.

Hortensius J, Slingerland RJ, Kleefstra N, Logtenberg SJ, Groenier KH, Houweling ST, Bilo HJ.

Diabetes Care. 2011 Mar;34(3):556-60. doi: 10.2337/dc10-1694. Epub 2011 Feb 2.

26.

Glycated haemoglobin A(1c) (HbA(1c) ) in the diagnosis of diabetes mellitus: don't forget the performance of the HbA(1c) assay.

Schindhelm RK, Lenters-Westra E, Slingerland RJ.

Diabet Med. 2010 Oct;27(10):1214-5. doi: 10.1111/j.1464-5491.2010.03088.x. No abstract available.

PMID:
20854391
27.

The influence of a soiled finger in capillary blood glucose monitoring.

Hortensius J, Kleefstra N, Slingerland RJ, Fokkert MJ, Groenier KH, Houweling ST, Bilo HJ.

Neth J Med. 2010 Aug;68(1):330-1. No abstract available.

28.

Self-monitoring of blood glucose in tablet-treated type 2 diabetic patients (ZODIAC).

Kleefstra N, Hortensius J, Logtenberg SJ, Slingerland RJ, Groenier KH, Houweling ST, Gans RO, van Ballegooie E, Bilo HJ.

Neth J Med. 2010 Aug;68(1):311-6.

29.

SKML-Quality Mark for point-of-care test (POCT) glucose meters and glucose meters for home-use.

Jansen RT, Slingerland RJ.

Clin Chem Lab Med. 2010 Jul;48(7):1021-7. doi: 10.1515/CCLM.2010.226.

PMID:
20459353
30.

Evaluation of the Quo-Test hemoglobin A1c point-of-care instrument: second chance.

Lenters-Westra E, Slingerland RJ.

Clin Chem. 2010 Jul;56(7):1191-3. doi: 10.1373/clinchem.2010.143149. Epub 2010 Apr 29. No abstract available.

31.

A double-blind, randomized, placebo-controlled clinical trial on benfotiamine treatment in patients with diabetic nephropathy.

Alkhalaf A, Klooster A, van Oeveren W, Achenbach U, Kleefstra N, Slingerland RJ, Mijnhout GS, Bilo HJ, Gans RO, Navis GJ, Bakker SJ.

Diabetes Care. 2010 Jul;33(7):1598-601. doi: 10.2337/dc09-2241. Epub 2010 Apr 22.

32.

Hemoglobin A1c point-of-care assays; a new world with a lot of consequences!

Lenters-Westra E, Slingerland RJ.

J Diabetes Sci Technol. 2009 May 1;3(3):418-23.

33.

Six of eight hemoglobin A1c point-of-care instruments do not meet the general accepted analytical performance criteria.

Lenters-Westra E, Slingerland RJ.

Clin Chem. 2010 Jan;56(1):44-52. doi: 10.1373/clinchem.2009.130641. Epub 2009 Nov 19.

34.

Iron-induced platelet aggregation measurement: a novel method to measure platelet function in stenting for ST segment elevation myocardial infarction.

Smit JJ, van Oeveren W, Ottervanger JP, Slingerland RJ, Remijn JA, Zijlstra F, van 't Hof AW.

Eur J Clin Invest. 2009 Feb;39(2):103-9. doi: 10.1111/j.1365-2362.2008.02069.x.

PMID:
19200163
35.

Pre- and postoperative accuracy and safety of a real-time continuous glucose monitoring system in cardiac surgical patients: a randomized pilot study.

Logtenberg SJ, Kleefstra N, Snellen FT, Groenier KH, Slingerland RJ, Nierich AP, Bilo HJ.

Diabetes Technol Ther. 2009 Jan;11(1):31-7. doi: 10.1089/dia.2008.0028.

PMID:
19132853
36.

Hemoglobin A1c determination in the A1C-Derived Average Glucose (ADAG) study.

Lenters-Westra E, Slingerland RJ.

Clin Chem Lab Med. 2008;46(11):1617-23. doi: 10.1515/CCLM.2008.322.

PMID:
19012527
37.

Association of 1,5-anhydroglucitol and 2-h postprandial blood glucose in type 2 diabetic patients: response to Stettler et al.

Schindhelm RK, Diamant M, Bilo HJ, Slingerland RJ.

Diabetes Care. 2008 Nov;31(11):e89; author reply e90. doi: 10.2337/dc08-1399. No abstract available. Erratum in: Diabetes Care. 2009 Jan;32(1):207.

PMID:
18955716
38.

Comparison of usefulness of C-reactive protein versus white blood cell count to predict outcome after primary percutaneous coronary intervention for ST elevation myocardial infarction.

Smit JJ, Ottervanger JP, Slingerland RJ, Kolkman JJ, Suryapranata H, Hoorntje JC, Dambrink JH, Gosselink AT, de Boer MJ, Zijlstra F, van 't Hof AW; On-TIME Study Group.

Am J Cardiol. 2008 Feb 15;101(4):446-51. doi: 10.1016/j.amjcard.2007.09.088.

PMID:
18312755
39.

Change of white blood cell count more prognostic important than baseline values after primary percutaneous coronary intervention for ST elevation myocardial infarction.

Smit JJ, Ottervanger JP, Kolkman JJ, Slingerland RJ, Suryapranata H, Hoorntje JC, Dambrink JH, Gosselink AT, de Boer MJ, van 't Hof AW, On-TIME study group.

Thromb Res. 2008;122(2):185-9. doi: 10.1016/j.thromres.2007.10.025. Epub 2008 Mar 4. No abstract available.

PMID:
18164377
40.

A case of very late stent thrombosis at high altitude.

van 't Hof AW, de Vries ST, Nadal F, Niella M, Fokkert MJ, Slingerland RJ, Maas AH, van Enst GC.

Thromb Haemost. 2007 Dec;98(6):1379-80. No abstract available.

PMID:
18064342
41.

Novel molecular defect in the platelet ADP receptor P2Y12 of a patient with haemorrhagic diathesis.

Remijn JA, IJsseldijk MJ, Strunk AL, Abbes AP, Engel H, Dikkeschei B, Dompeling EC, de Groot PG, Slingerland RJ.

Clin Chem Lab Med. 2007;45(2):187-9.

PMID:
17311506
42.

Predictors of elevated cardiac troponin T on admission in ST-segment elevation myocardial infarction.

Rasoul S, Nienhuis MB, Ottervanger JP, Slingerland RJ, de Boer MJ, Dambrink JH, Ernst NM, Hoorntje JC, Gosselink AT, Suryapranata H, Zijlstra F, van 't Hof AW.

Ann Clin Biochem. 2006 Jul;43(Pt 4):281-6.

PMID:
16824278
43.

Successful reperfusion for acute ST elevation myocardial infarction is associated with a decrease in WBC count.

Smit JJ, Ottervanger JP, Slingerland RJ, Suryapranata H, Hoorntje JC, Dambrink JH, Gosselink AT, de Boer MJ, van 't Hof AW.

J Lab Clin Med. 2006 Jun;147(6):321-6.

PMID:
16750670
44.

Platelet microaggregation inhibition in patients with acute myocardial infarction pretreated with tirofiban and relationship with angiographic and clinical outcome.

Smit JJ, Ernst NM, Slingerland RJ, Kolkman JJ, Suryapranata H, Hoorntje JC, Dambrink JH, Ottervanger JP, Gosselink AT, de Boer MJ, van 't Hof AW; On-TIME Study Group.

Am Heart J. 2006 May;151(5):1102-7.

PMID:
16644344
45.

Achieved platelet aggregation inhibition after different antiplatelet regimens during percutaneous coronary intervention for ST-segment elevation myocardial infarction.

Ernst NM, Suryapranata H, Miedema K, Slingerland RJ, Ottervanger JP, Hoorntje JC, Gosselink AT, Dambrink JH, de Boer MJ, Zijlstra F, van 't Hof AW.

J Am Coll Cardiol. 2004 Sep 15;44(6):1187-93.

46.

The predictive value of cumulative lactate dehydrogenase release within the first 72 h of acute myocardial infarction in patients treated with primary angioplasty.

Elsman P, Zijlstra F, Miedema K, Hoorntje JC, Dikkeschei LD, Slingerland RJ, Reiffers S, de Boer MJ, Suryapranata H.

Ann Clin Biochem. 2004 Mar;41(Pt 2):142-8.

PMID:
15025806
47.

Evaluation of portable blood glucose meters. Problems and recommendations.

Slingerland RJ, Miedema K.

Clin Chem Lab Med. 2003 Sep;41(9):1220-3.

PMID:
14598872
48.

High-performance liquid chromatographic analysis of biogenic amines in cells and in culture media using on-line dialysis and trace enrichment.

Slingerland RJ, Van Kuilenburg AB, Bodlaender JM, Overmars H, Voûte PA, Van Gennip AH.

J Chromatogr B Biomed Sci Appl. 1998 Sep 25;716(1-2):65-75.

PMID:
9824219
49.

Determination of CTP synthetase activity in crude cell homogenates by a fast and sensitive non-radiochemical assay using anion-exchange high-performance liquid chromatography.

Van Kuilenburg AB, Elzinga L, Verschuur AC, Van den Berg AA, Slingerland RJ, Van Gennip AH.

J Chromatogr B Biomed Sci Appl. 1997 Jun 6;693(2):287-95.

PMID:
9210431
50.

In-situ cytidine-deaminase activity and chromosome 1P deletion in human neuroblastoma cells.

Slingerland RJ, Van Gennip AH, Bodlaender JM, Voûte PA, Van Kuilenburg AB.

Anticancer Res. 1997 Jan-Feb;17(1A):457-9.

PMID:
9066694

Supplemental Content

Loading ...
Support Center